|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1997-11-3
|
|
pubmed:abstractText |
To compare the efficacy, safety and tolerability of valsartan to an angiotensin-converting enzyme (ACE) inhibitor, lisinopril, and placebo in patients with mild-to-moderate essential hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0950-9240
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
483-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9322828-Adult,
pubmed-meshheading:9322828-Aged,
pubmed-meshheading:9322828-Aged, 80 and over,
pubmed-meshheading:9322828-Angiotensin II,
pubmed-meshheading:9322828-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9322828-Antihypertensive Agents,
pubmed-meshheading:9322828-Blood Pressure,
pubmed-meshheading:9322828-Dose-Response Relationship, Drug,
pubmed-meshheading:9322828-Double-Blind Method,
pubmed-meshheading:9322828-Female,
pubmed-meshheading:9322828-Follow-Up Studies,
pubmed-meshheading:9322828-Humans,
pubmed-meshheading:9322828-Hypertension,
pubmed-meshheading:9322828-Lisinopril,
pubmed-meshheading:9322828-Male,
pubmed-meshheading:9322828-Middle Aged,
pubmed-meshheading:9322828-Safety,
pubmed-meshheading:9322828-Tetrazoles,
pubmed-meshheading:9322828-Treatment Outcome,
pubmed-meshheading:9322828-Valine
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril.
|
|
pubmed:affiliation |
Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
